Radiant Innovation

Radiant Innovation Net Tangible Assets

The Net Tangible Assets of Radiant Innovation (3373.TWO) as of Nov 20, 2026 is 793.81 M TWD. In the previous year, Net Tangible Assets was 865.89 M TWD — a change of -8.33% (lower).

Net Tangible Assets

793.81 MTWD

YoY

-8.33%

Last updated:

Net Tangible Assets of Radiant Innovation is 2025 793.81 M TWD. Net Tangible Assets of Radiant Innovation was 2024 865.89 M TWD. It decreases by -8.33% lower compared to the previous year.

The Radiant Innovation Net Tangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Tangible Assets
Date
Net Tangible Assets
Jan 1, 2018
660.40 M TWD
Jan 1, 2019
656.46 M TWD
Jan 1, 2020
1.34 B TWD
Jan 1, 2021
1.06 B TWD
Jan 1, 2022
1.02 B TWD
Jan 1, 2023
918.69 M TWD
Jan 1, 2024
865.89 M TWD
Jan 1, 2025
793.81 M TWD
The Radiant Innovation Net Tangible Assets history
YEARNet Tangible AssetsYoY
793.81 MTWD-8.33%
865.89 MTWD-5.75%
918.69 MTWD-9.68%
1.02 BTWD-4.12%
1.06 BTWD-21.04%
1.34 BTWD+104.67%
656.46 MTWD-0.60%
660.40 MTWD-0.64%
664.65 MTWD-1.48%
674.65 MTWD-6.49%
721.47 MTWD+3.22%
698.96 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Radiant Innovation Stock analysis

What does Radiant Innovation do? Radiant Innovation Inc. generates revenue through the design, manufacture, and sale of infrared technology products. The company's main products include infrared temperature measurement instruments, ear temperature guns, frontal temperature guns, and other body temperature measurement products, alongside carbon dioxide detectors, infrared thermal imagers, and blood glucose dedicated chipsets. These products are distributed domestically and internationally across Asia, the Americas, Europe, and other regions. The primary buyers are healthcare providers, medical facilities, and electronic component distributors who require precise measurement tools and specialized components for health monitoring and diagnostics. The firm's product portfolio targets healthcare and industrial segments, with infrared thermal imagers used in building inspections and carbon dioxide detectors deployed in environmental monitoring. Blood glucose dedicated chipsets are supplied to medical device manufacturers for integration into diagnostic equipment. International distribution channels focus on regions like Asia, the Americas, and Europe, where demand for health-related measurement devices remains strong. Revenue streams are driven by direct sales to medical institutions, electronic component distributors, and industrial clients. The company's product lines serve both consumer-facing health monitoring applications and specialized industrial uses, with a strong emphasis on accuracy and reliability in temperature and gas detection technologies. Radiant Innovation is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Radiant Innovation stock

Net Tangible Assets of Radiant Innovation is 793.81 M TWD in 2025.

Net Tangible Assets of Radiant Innovation changed from 865.89 M TWD to 793.81 M TWD, representing a -8.33% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Tangible Assets Radiant Innovation since 2006 – with annual values, charts, and detailed analysis.

Net tangible assets equal total assets minus intangible assets, goodwill, and liabilities. They represent the physical asset backing of a company.

Net Tangible Assets's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Tangible Assets's Radiant Innovation historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Radiant Innovation

All Key Metrics — Radiant Innovation